Exelixis Inc (EXEL)
Healthcare
Biotechnology
53.00 $
-5.3%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Exelixis Inc (EXEL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 81.3% of the shares are freely tradable; institutional investors hold 107.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
107.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.8%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
81.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
16.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
251Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 12.26 | 30,816,309 | +2.0 | 03/31/2026 |
| Renaissance Technologies Corp | 5.46 | 13,726,993 | -1.3 | 03/31/2026 |
| Farallon Capital Management, L.L.C. | 5.22 | 13,111,010 | -16.5 | 03/31/2026 |
| AQR Capital Management LLC | 5.21 | 13,095,741 | -4.1 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.81 | 12,085,273 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.48 | 11,258,984 | +0.0 | 03/31/2026 |
| State Street Corp | 4.10 | 10,298,439 | -1.8 | 03/31/2026 |
| Fuller & Thaler Asset Management Inc | 3.40 | 8,542,236 | -46.3 | 03/31/2026 |
| Geode Capital Management, LLC | 3.10 | 7,795,610 | +3.5 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.42 | 8,600,209 | +0.2 | 07/28/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.